These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38300678)

  • 41. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.
    Newman CM; Price A; Davies DW; Gray TA; Weetman AP
    Heart; 1998 Feb; 79(2):121-7. PubMed ID: 9538302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction.
    Yamato M; Wada K; Hayashi T; Fujimoto M; Hosomi K; Oita A; Takada M
    Clin Drug Investig; 2018 Jan; 38(1):39-48. PubMed ID: 29080209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Amiodarone and thyroid disorders--prospective study and review of the literature].
    Vandergheynst F; Liénart F; Ducobu J
    Rev Med Brux; 1999 Oct; 20(5):411-7. PubMed ID: 10582476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amiodarone-induced thyrotoxicosis.
    Schubert L; Bricaire L; Groussin L
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):163-166. PubMed ID: 32409004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Amiodarone-induced thyrotoxicosis: case report and review of the literature].
    Bianconcini M; Giannini AL
    Ital Heart J Suppl; 2003 Aug; 4(8):682-7. PubMed ID: 14655464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Iodine excess induced thyroid dysfunction].
    Egloff M; Philippe J
    Rev Med Suisse; 2016 Apr; 12(515):804-9. PubMed ID: 27276725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amiodarone-induced thyroid dysfunction in an iodine-replete area: epidemiological and clinical data.
    Zosin I; Balaş M
    Endokrynol Pol; 2012; 63(1):2-9. PubMed ID: 22378090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age and thyroid hormone replacement delays the recovery from amiodarone-induced hypothyroidism.
    Huang JH; Lin YK; Hsieh MH; Chiu WC; Chen YJ
    Int J Cardiol; 2016 Jan; 202():561-3. PubMed ID: 26447662
    [No Abstract]   [Full Text] [Related]  

  • 49. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
    Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
    J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thyroid dysfunction and amiodarone].
    Lima J; Carvalho P; Molina MA; Rebelo M; Dias P; Vieira JD; Costa JM
    Arq Bras Endocrinol Metabol; 2013 Feb; 57(1):71-8. PubMed ID: 23440102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
    Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amiodarone-induced hypothyroidism and other adverse effects.
    Mosher MC
    Dimens Crit Care Nurs; 2011; 30(2):87-93. PubMed ID: 21307683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amiodarone and thyrotoxicosis: case reports.
    Tavares AB; Paula SK; Vaisman M; Teixeira Pde F
    Arq Bras Cardiol; 2010 Oct; 95(5):e122-4. PubMed ID: 21225109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lithium treatment in amiodarone-induced thyrotoxicosis.
    Dickstein G; Shechner C; Adawi F; Kaplan J; Baron E; Ish-Shalom S
    Am J Med; 1997 May; 102(5):454-8. PubMed ID: 9217642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis.
    Cappiello E; Boldorini R; Tosoni A; Piraneo S; Bernasconi R; Raggi U
    J Endocrinol Invest; 1995 Dec; 18(11):862-8. PubMed ID: 8778159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Amiodarone and the thyroid].
    Martino E; Bartalena L; Bogazzi F; Brogioni S; Aghini-Lombardi F; Manetti L; Tanda ML
    Cardiologia; 1995 Dec; 40(12 Suppl 1):173-8. PubMed ID: 8998711
    [No Abstract]   [Full Text] [Related]  

  • 58. Amiodarone and the thyroid: a 2012 update.
    Bogazzi F; Tomisti L; Bartalena L; Aghini-Lombardi F; Martino E
    J Endocrinol Invest; 2012 Mar; 35(3):340-8. PubMed ID: 22433945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Amiodarone and the thyroid].
    Lahera Vargas M; de Luis Román D; Hervilla Ezquerra S; Maldonado Castro G; Zurita Sepúlveda P
    Rev Clin Esp; 1999 Apr; 199(4):227-32. PubMed ID: 10364796
    [No Abstract]   [Full Text] [Related]  

  • 60. Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland.
    Kurnik D; Loebstein R; Farfel Z; Ezra D; Halkin H; Olchovsky D
    Medicine (Baltimore); 2004 Mar; 83(2):107-113. PubMed ID: 15028964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.